Original Musical If/Then Dazzles Audiences Across the Country
February 9, 2016
Get the details on the inspiration behind this new, ambitious production
If/Then is a contemporary new musical starring Elizabeth, a city planner who moves back to New York to restart her life. But when her carefully designed plans collide with the whims of fate, Elizabeth’s life splits into two parallel paths. If/Then follows both stories simultaneously as this modern woman faces the intersection of choice and chance.
The Balancing Act’s correspondent, Amber Milt, takes viewers to New York City where she will hear firsthand from the creative team as they talk about the inspiration behind this new, ambitious production and the process of building an original musical. We’ll hear from the Pulitzer Prize and Tony Award-winning team of Tom Kitt (Music) and Brian Yorkey (Book and Lyrics), along with one of the show’s producers Patrick Catullo.
In addition to the creative team, viewers will go behind the scenes of rehearsals for the upcoming national tour where they’ll meet and hear from original Broadway cast members Tony Award winners LaChanze, Anthony Rapp and James Snyder. We’ll also hear from audience members who talk about what the show means to them and how we can all relate to the themes within this thought-provoking musical.
Catch all the action on The Balancing Act, Tuesday, May 31 and June 7, 2016 at 7:30 a.m. (ET/PT). To purchase tickets to If/Then, learn more about where the show is headed next, and for even more exclusive content, go to www.BroadwayBalancesAmerica.com.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.